Cargando…

Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment

BACKGROUND: Although impaired myeloid-derived suppressor cells (MDSCs) recently have been studied in immune thrombocytopenia (ITP), another myeloid-derived cell population signified as M2 macrophages has not been investigated properly in ITP patients. In the present study, we intended to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Xia, Wu, Boting, Cheng, Luya, Li, Feng, Zhan, Yanxia, Liu, Chanjuan, Ji, Lili, Min, Zhihui, Ke, Yang, Sun, Lihua, Chen, Hao, Cheng, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833082/
https://www.ncbi.nlm.nih.gov/pubmed/29499727
http://dx.doi.org/10.1186/s12967-018-1424-8
_version_ 1783303422147035136
author Shao, Xia
Wu, Boting
Cheng, Luya
Li, Feng
Zhan, Yanxia
Liu, Chanjuan
Ji, Lili
Min, Zhihui
Ke, Yang
Sun, Lihua
Chen, Hao
Cheng, Yunfeng
author_facet Shao, Xia
Wu, Boting
Cheng, Luya
Li, Feng
Zhan, Yanxia
Liu, Chanjuan
Ji, Lili
Min, Zhihui
Ke, Yang
Sun, Lihua
Chen, Hao
Cheng, Yunfeng
author_sort Shao, Xia
collection PubMed
description BACKGROUND: Although impaired myeloid-derived suppressor cells (MDSCs) recently have been studied in immune thrombocytopenia (ITP), another myeloid-derived cell population signified as M2 macrophages has not been investigated properly in ITP patients. In the present study, we intended to determine the features of circulating M2-like macrophages, to examine its relationship with MDSCs, and to explore their prognostic values in ITP. METHODS: Peripheral blood mononuclear cells from healthy controls and primary ITP patients were isolated to test the circulating M2-like macrophages and MDSCs. The circulating M2-like macrophage population defined as CD68(+)CD163(+) and circulating MDSC population as CD11b(+)CD33(+)HLA-DR(−) were determined by flow cytometry. Plasma inflammatory cytokines were measured by multiplex ELISA. RESULTS: The percentages of MDSCs were found to be expanded in newly diagnosed patients of ITP, especially among those of the complete response (CR) group (p < 0.0001). Positive linear correlation was verified between percentages of M2-like macrophages and MDSCs. The same correlation was also determined in the CR group. After treatment, the percentages of M2-like macrophages and MDSCs were both increased significantly in CR group, while those patients among the PR + NR group manifested a significant numeric decrease of MDSCs but only a moderate decrease in M2-like macrophages. MIP-1α/CCL3 was negatively correlated with M2-like macrophages while MCP-1 possessed a positive correlation with M2-like macrophages, eotaxin-1/CCL11 was negatively correlated with MDSCs and interleukin-1β (IL-1β) was found to be negatively correlated with both M2-like macrophages and MDSCs. CONCLUSIONS: The present findings indicated critical roles of both circulating M2-like macrophages and MDSCs in ITP. The positive correlation between them might be related to inflammatory factors-mediated bidirectional interactions or partially due to their similar background patterns during differentiation. MIP-1α/CCL3, MCP-1, eotaxin-1/CCL11 and IL-1β might play a critical role in the expansion of both M2 macrophages and MDSCs population in ITP patients, which deserves further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1424-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5833082
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58330822018-03-05 Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment Shao, Xia Wu, Boting Cheng, Luya Li, Feng Zhan, Yanxia Liu, Chanjuan Ji, Lili Min, Zhihui Ke, Yang Sun, Lihua Chen, Hao Cheng, Yunfeng J Transl Med Research BACKGROUND: Although impaired myeloid-derived suppressor cells (MDSCs) recently have been studied in immune thrombocytopenia (ITP), another myeloid-derived cell population signified as M2 macrophages has not been investigated properly in ITP patients. In the present study, we intended to determine the features of circulating M2-like macrophages, to examine its relationship with MDSCs, and to explore their prognostic values in ITP. METHODS: Peripheral blood mononuclear cells from healthy controls and primary ITP patients were isolated to test the circulating M2-like macrophages and MDSCs. The circulating M2-like macrophage population defined as CD68(+)CD163(+) and circulating MDSC population as CD11b(+)CD33(+)HLA-DR(−) were determined by flow cytometry. Plasma inflammatory cytokines were measured by multiplex ELISA. RESULTS: The percentages of MDSCs were found to be expanded in newly diagnosed patients of ITP, especially among those of the complete response (CR) group (p < 0.0001). Positive linear correlation was verified between percentages of M2-like macrophages and MDSCs. The same correlation was also determined in the CR group. After treatment, the percentages of M2-like macrophages and MDSCs were both increased significantly in CR group, while those patients among the PR + NR group manifested a significant numeric decrease of MDSCs but only a moderate decrease in M2-like macrophages. MIP-1α/CCL3 was negatively correlated with M2-like macrophages while MCP-1 possessed a positive correlation with M2-like macrophages, eotaxin-1/CCL11 was negatively correlated with MDSCs and interleukin-1β (IL-1β) was found to be negatively correlated with both M2-like macrophages and MDSCs. CONCLUSIONS: The present findings indicated critical roles of both circulating M2-like macrophages and MDSCs in ITP. The positive correlation between them might be related to inflammatory factors-mediated bidirectional interactions or partially due to their similar background patterns during differentiation. MIP-1α/CCL3, MCP-1, eotaxin-1/CCL11 and IL-1β might play a critical role in the expansion of both M2 macrophages and MDSCs population in ITP patients, which deserves further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1424-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-02 /pmc/articles/PMC5833082/ /pubmed/29499727 http://dx.doi.org/10.1186/s12967-018-1424-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Shao, Xia
Wu, Boting
Cheng, Luya
Li, Feng
Zhan, Yanxia
Liu, Chanjuan
Ji, Lili
Min, Zhihui
Ke, Yang
Sun, Lihua
Chen, Hao
Cheng, Yunfeng
Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
title Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
title_full Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
title_fullStr Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
title_full_unstemmed Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
title_short Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
title_sort distinct alterations of cd68(+)cd163(+) m2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without cr after high-dose dexamethasone treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833082/
https://www.ncbi.nlm.nih.gov/pubmed/29499727
http://dx.doi.org/10.1186/s12967-018-1424-8
work_keys_str_mv AT shaoxia distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT wuboting distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT chengluya distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT lifeng distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT zhanyanxia distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT liuchanjuan distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT jilili distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT minzhihui distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT keyang distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT sunlihua distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT chenhao distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment
AT chengyunfeng distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment